Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
aMoon Fund is a global venture capital fund based in Israel, established in 2017 by Dr. Yair Schindel and Marius Nacht. The fund focuses on transforming healthcare by investing in innovative companies that leverage groundbreaking science and technology. aMoon aims to accelerate the development of solutions that address high unmet medical needs, positioning itself as a key player in the HealthTech sector.
Currently, aMoon Fund manages over $1.1 billion in assets under management (AUM) and operates multiple funds, including aMoon Velocity and aMoon Growth. The organization has made significant strides since its inception, establishing itself as a leader in the healthcare investment space. Notable milestones include the successful acquisition of portfolio company VIRX by Nanox, showcasing the fund's ability to identify and support high-potential companies.
Headquartered in Israel, aMoon Fund has a global investment focus, with particular interest in Asia. The firm is committed to building partnerships between its portfolio companies and leaders in technology, finance, and medical research, enhancing growth and innovation across the healthcare landscape.
aMoon Fund invests in both early and late-stage companies, targeting disruptive technologies in the healthcare sector. The fund's investment stages range from pre-seed to growth equity, allowing it to engage with companies at various points in their development. aMoon Velocity and aMoon Growth funds are specifically designed to support companies generating revenue or those in pivotal clinical trials, ensuring that investments are directed towards high-impact opportunities.
Additionally, aMoon operates an Edge Fund that focuses on IPO and public equity opportunities, further diversifying its investment strategy. The firm seeks to build partnerships between its portfolio companies and key players in global tech, finance, and medical research, which enhances the potential for successful outcomes. aMoon's investment thesis emphasizes the importance of addressing high unmet medical needs through innovative solutions, making it a compelling partner for startups in the healthcare and biotech sectors.
aMoon Fund's portfolio includes a diverse range of companies focused on healthcare and biotechnology. Notable portfolio companies include:
Other highlights from aMoon's portfolio include DayTwo, which specializes in microbiome solutions, Sight Diagnostics, known for AI blood testing, and Ibex Medical Analytics, focusing on AI-driven pathology solutions. This strong emphasis on healthcare AI underscores aMoon's commitment to investing in technologies that can significantly impact patient care and outcomes.
Dr. Yair Schindel - Co-Founder & Managing Partner. Dr. Schindel has extensive experience in healthcare and venture capital, holding an MD and MBA. He has been instrumental in shaping aMoon's investment strategy.
Marius Nacht - Co-Founder. Nacht is a co-founder of Check Point Software Technologies and brings deep expertise in cybersecurity and technology to the healthcare sector.
Tomer Berkovitz - Managing Partner. Berkovitz holds a PhD and has a strong background in healthcare investments, focusing on innovative technologies.
Todd Sone - General Partner. Sone has an MBA and extensive experience in venture capital, particularly in the healthcare space.
Moshic Mor - General Partner. Mor holds an MBA and has a background in technology investments, contributing to aMoon's focus on disruptive healthcare solutions.
Yaron Daniely - General Partner & Head of aMoon Alpha. Daniely holds a PhD and MBA, specializing in healthcare innovation and investment.
Reut Shema - Partner. Shema holds a PhD and focuses on healthcare technology investments.
Roy Wiesner - Partner. Wiesner is an attorney with an MPA, bringing legal expertise to the firm.
Patrick Rivers - Portfolio Manager. Rivers has an MBA and manages aMoon's portfolio investments.
Irena Katsman - Chief Financial Officer. Katsman is a CPA with an MBA, overseeing the fund's financial operations.
Noam Waldoks - Chief Legal Officer. Waldoks holds a JD and provides legal guidance for the fund.
Osnat Tirosh - Chief People Officer & Chief of Staff. Tirosh manages human resources and organizational operations.
Noah Lasson - Chief Compliance Officer & CISO. Lasson holds a JD and MBA, ensuring compliance and security for the fund.
Gaby Hirsch - VP Investor Relations. Hirsch manages relationships with investors and stakeholders.
Yodfat Melzer - VP Finance. Melzer is a CPA with an MBA, overseeing financial strategy.
Elinor Belkine Michaeli - Director of Operations. Michaeli manages day-to-day operations of the fund.
Maya Tollman Toledano - Senior Legal Counsel. Toledano provides legal support for portfolio companies.
To pitch aMoon Fund, interested parties should email their proposals to info@amoon.fund. It is recommended to include a comprehensive deck that outlines the business model, market opportunity, and team qualifications. While specific response time expectations are not disclosed, founders should anticipate a thorough review process given the fund's focus on high-impact investments.
Warm introductions are preferred, as they can facilitate a more favorable review of proposals. Founders are encouraged to leverage their networks to connect with aMoon's team or existing portfolio companies for introductions.
In 2021, aMoon Fund launched its second fund, raising $300 million to further its investment strategy in healthcare innovation. This fund aims to support companies at various stages, from early development to growth equity.
Recently, aMoon Fund has been actively involved in partnerships with key players in global tech, finance, and medical research, enhancing its portfolio companies' growth potential. The firm continues to seek opportunities that align with its mission to transform healthcare through innovative investments.
What are aMoon Fund's investment criteria?
aMoon Fund targets companies in the healthcare, biotech, and AI sectors, focusing on disruptive technologies that address high unmet medical needs. The fund invests in both early and late-stage companies, particularly those generating revenue or in pivotal clinical trials.
How can startups apply or pitch to aMoon Fund?
Startups interested in pitching to aMoon Fund can submit their proposals via email at info@amoon.fund. It is advisable to include a detailed business plan and information about the team and technology.
What makes aMoon Fund different from other venture capital firms?
aMoon Fund is Israel's largest HealthTech venture capital fund, with a strong focus on healthcare innovation. The firm leverages its extensive network in global tech, finance, and medical research to facilitate partnerships that enhance growth and innovation for its portfolio companies.
What is the geographic scope of aMoon Fund's investments?
aMoon Fund has a global investment focus, with particular interest in Asia. This allows the firm to tap into diverse markets and opportunities within the healthcare sector.
What is the typical check size for investments made by aMoon Fund?
While specific check sizes are not disclosed, aMoon Fund invests across various stages, from pre-seed to growth equity, indicating a flexible approach to funding based on the needs of the portfolio companies.
What kind of post-investment involvement does aMoon Fund have?
aMoon Fund provides significant value-add to its portfolio companies by leveraging its extensive network and facilitating partnerships that enhance growth. The firm is actively involved in supporting its companies through operational guidance and strategic connections.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.